To evaluate if a new investigational drug is safe and effective in improving
symptoms of mild to moderate Alzheimer’s disease.
You or someone you know may be eligible if you:
♦ Are between 55 and 85 years of age
♦ Have been diagnosed with Alzheimer’s
disease
♦ Have a reliable support person or caregiver
who is willing to participate in study visits,
report on daily activities and oversee or
help you with taking ATH-1017